WiLing Wednesdays Education Webinars
Women in Lymphoma is very grateful for the generous sponsorship from industry supporters around the world.
Thank you for your ongoing support of our projects!
WiLing Wednesdays educational webinars hosted by Women in Lymphoma are solely intended for professionals working in the field of lymphoma. All patients seeking guidance or support with a lymphoma diagnosis or treatment are advised to consult their specialist haematologist.
______________________________________________________________________________________________
SERIES 16 - MCL - Oct/Nov 2025
SERIES 15 - PATHOGENS AND LYMPHOMA - July 2025
Session 1 - EBV and lymphomagenesis - Marie Donzel, Jennifer Amengual. recording
Session 2 - Microbiome in lymphomas - Catherine Diefenbach, Paola Ghione. recording
Session 3 - Do infectious agents drive lymphoma initiation? - Catherine Thieblemont, Ayako Arai. recording
Session 4 - Post-treatment risk for infection - Swetha Thiruvengadam, Sairah Ahmed, Mini Kamboj. recording
SERIES 14 - DEMYSTIFYING PHARMA - Apr/May 2025
Session 1 - Pharma Structure - Michelle Dawson, Nina Shah. recording
Session 2 - Industry Engagement - Clare Spooner, John Wahba, Suhaida Selamat. recording
Session 3 - Successful Research Collaboration - Julia Brain, Candice McCoy. recording
Session 4 - Careers in Pharma - Connie Batlevi, Jamie Hirata. recording
SERIES 13 - INDOLENT LYMPHOMA - Oct/Nov 2024
Session 1 - First step of lymphomagenesis (t14;18 & CREBBP) - Dr. Sandrine Roulland & The CPC in its niche - Dr. Karin Tarte. recording
Session 2 - Biological Determinants of Progression and Transformation of Follicular Lymphoma - Prof. Jess Okosun & Risk stratification versus genomic classification in FL - Carla Casulo, MD. recording
Session 3 - First line for LTB & HTB - Dr Clémentine Sarkozy & RELEVANCE and preliminary data on PET as a biomarker, including its combination with ctDNA, recent advances in radiomics - Dr Anne-Ségolène Cottereau. recording
Session 4 - DEBATE : High risk relapsed FL should be treated differently. FOR – Dr Kim Linton & AGAINST – Dr Astrid Pavlovsky. recording
Session 5 - Career Development. recording
SERIES 12 - HODGKIN LYMPHOMA - May/June 2024
Session 1 - Strategies to Tailor Treatment for Hodgkin Lymphoma. recording
Session 2 - Global Perspectives on Treatment of Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma with a Focus on Advanced Stage. recording
Session 3 - Current/Forthcoming Clinical Trials in Hodgkin Lymphoma. recording
Session 4 - Nodular Lymphoma Predominant Hodgkin Lymphoma and Other Pathologic Phenomena in Hodgkin Lymphoma. recording
SERIES 11 – DLBCL - March/April 2024
Session 1 - Upfront DLBCL Therapy. recording
Session 2 - The Changing Algorithm in R/R DLBCL. recording
Session 3 - Expanding Novel Therapies in R/R DLBCL. recording
Session 4 - Tailoring Therapy in R/R DLBCL. recording
Session 5 - Update on DLBCL Classification. recording
SERIES 10 – CAREER DEVELOPMENT - Oct/Nov 2023
Session 1 - Navigating early career development: Mentorship and Academic Promotion. recording
Session 2 - Tips & Pearls for Publishing Success. recording
Session 3 - Identifying and Pursuing Research Opportunities and Cooperative work. recording
Session 4 - Making Meaning in the Second half of your Career – leadership planning and new experiences. recording
SERIES 9 – MANTLE CELL LYMPHOMA (MCL) - May 2023
Session 1 - MCL Treatment. recording
Session 2 - MCL Prognostication. recording
Session 3 - Pathogenesis & Biology. recording
SERIES 8 – CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) - Feb/Mar 2023
Session 1 - CLL frontline treatment/new drugs/global access. recording
Session 2 - Tough CLL. recording
Session 3 - Career Development. recording
Session 4 - Optimal Investigation of CLL - molecular studies, risk stratification & MRD. recording
SERIES 7 - LYMPHOMA & THE BRAIN - Sept/Oct 2022
Session 1 - PCSNL - Diagnosis and Treatment. recording
Session 2 - PSNSL - Elderly and side effects. recording
Session 3 - SCNSL and CAR-T. recording
Session 4 - Debate on CNS Prophylaxis. recording
Session 5 - Other brain lymphomas & imaging. recording
SERIES 6 - CELLULAR THERAPY - Apr/May 2022
Session 1- Defining Cellular Therapies. recording
Session 2 - CAR-T Cells in different clinical settings - Treatment of DLBCL/Treatment of FL, MCL, CLL. recording
Session 3 - Moving forward in CAR-T Cell - Mechanisms of Resistance/Modified CAR-T Strategies – Allo CAR-T, Dual CAR-T. recording
Session 4 - CAR-T Strategies vs. BiTes. recording
Session 5 - Global discussion on access, application, real-life experiences & challenges. recording
SERIES 5 - CAREER DEVELOPMENT - Mar/Apr 2022
Session 1 - APPs. recording
Session 2 - Legendary WiL. recording
SERIES 4 – INDOLENT LYMPHOMA - Oct/Nov 2021
Session 1 - Living with Follicular Lymphoma/Follicular Lymphoma pathogenesis and clonal evolution, transformed FL. recording
Session 2 - Risk stratification in Follicular Lymphoma/Utility of PET in Follicular Lymphoma. recording
Session 3 - Advances for treatment for Follicular Lymphoma/Treatment paradigms for relapsed and refractory Follicular Lymphoma. recording
Session 4A - Career Development with Change Champions and their Mentees. recording
Session 4B - Career Development with Change Champions and their Mentees. recording
Session 5 - Treatment options in Marginal Zone Lymphoma/Waldenstrom’s Macroglobulinemia. recording
SERIES 3 - T-CELL LYMPHOMA - Apr/May 2021
Session 1- Update on T-cell: Lymphoma HemPath review/Primary therapy of common peripheral T-cell lymphoma. recording
Session 2 - HemPath review of T-cell lymphomas common in Asia/Frontline & Salvage therapies for T-cell lymphomas common in Asia. recording
Session 3 - Treatment & outcome for relapsed T-cell lymphomas/Use of autologous & allogenuc transplant for T-cell lymphomas. recording
Session 4 - Newer therapies & Clinical trials for T-cell lymphomas/Case studies of T-cell lymphomas. recording
Session 5 - Career Development. recording
SERIES 2 - HODGKIN LYMPHOMA - Jan/Feb 2021
Session 1 - Harnessing The Immune System To Treat Hodgkin Lymphoma. recording
Session 2 - Radiation In HL: A Showcase Of An Ideal Therapeutic Ratio. recording
Session 3 - Optimising The Care Of Aya Hodgkin Lymphoma. recording
Session 4 - Hodgkin Lymphoma Cases: A Global Discussion. recording
Session 5 - Career Reflections. recording
SERIES 1 - DLBCL - Sept 2020
Unfortunately recordings are not available for this series.
Session 1 - How I Approach Newly Diagnosed DLBCL
Session 2 - How I manage relapsed DLBCL
Session 3 - PET-pearls & PET-pitfalls in DLBCL
Session 4 - DLBCL: Lessons learnt from LYSA clinical trials
Session 5 - CNS Prophylaxis in Diffuse Large B Cell Lymphoma